BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7912821)

  • 1. Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems.
    Xiao-Jun X; Jing-Xia H; Seiger Å; Hughes J; Hökfelt T; Wiesenfeld-Hallin Z
    Pain; 1994 Mar; 56(3):271-277. PubMed ID: 7912821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that spinal endogenous opioidergic systems control the expression of chronic pain-related behaviors in spinally injured rats.
    Hao JX; Yu W; Xu XJ
    Exp Brain Res; 1998 Jan; 118(2):259-68. PubMed ID: 9547096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central inhibitory dysfunctions: mechanisms and clinical implications.
    Wiesenfeld-Hallin Z; Aldskogius H; Grant G; Hao JX; Hökfelt T; Xu XJ
    Behav Brain Sci; 1997 Sep; 20(3):420-5; discussion 435-513. PubMed ID: 10097004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
    Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
    Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats.
    Kim J; Kim JH; Kim Y; Cho HY; Hong SK; Yoon YW
    Neurosci Lett; 2009 Oct; 462(3):303-7. PubMed ID: 19619609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors.
    Gustafsson H; de Araújo Lucas G; Schött E; Stiller CO; Alster P; Wiesenfeld-Hallin Z; Brodin E
    Brain Res; 1998 Apr; 790(1-2):141-50. PubMed ID: 9593865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats.
    Xu XJ; Alster P; Wu WP; Hao JX; Wiesenfeld-Hallin Z
    Peptides; 2001 Aug; 22(8):1305-8. PubMed ID: 11457525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury.
    Xu XJ; Hao JX; Aldskogius H; Seiger Å; Wiesenfeld-Hallin Z
    Pain; 1992 Feb; 48(2):279-290. PubMed ID: 1589248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury.
    Yu W; Hao JX; Xu XJ; Saydoff J; Haegerstrand A; Hökfelt T; Wiesenfeld-Hallin Z
    Pain; 1998 Feb; 74(2-3):115-22. PubMed ID: 9520225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
    Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
    Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury.
    Wu WP; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Koek W; Colpaert FC
    Eur J Pharmacol; 2003 Oct; 478(2-3):131-7. PubMed ID: 14575797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
    Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.
    Kovelowski CJ; Ossipov MH; Sun H; Lai J; Malan TP; Porreca F
    Pain; 2000 Sep; 87(3):265-273. PubMed ID: 10963906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allodynia-like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation.
    Hao XJ; Xu JX; Aldskogius H; Seiger Å; Wiesenfeld-Hallin Z
    Pain; 1991 May; 45(2):175-185. PubMed ID: 1652116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury.
    Hao JX; Stöhr T; Selve N; Wiesenfeld-Hallin Z; Xu XJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):135-40. PubMed ID: 17092498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia.
    Rivat C; Becker C; Blugeot A; Zeau B; Mauborgne A; Pohl M; Benoliel JJ
    Pain; 2010 Aug; 150(2):358-368. PubMed ID: 20573451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
    Yamamoto T; Sakashita Y
    Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
    Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7105-9. PubMed ID: 1698290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.